Publication
Cannabis’ legalization and what it means for regulatory regimes worldwide
Cannabis has been considered an illegal substance globally since the creation of the Single Convention on Narcotic Drugs (The Convention) in 1961.
Global | Publication | October 2020
Our global Food and Agribusiness team has a deep understanding of the existing and emerging issues surrounding the global cannabis industry. Cannabis is a sector in a state of rapid transition globally, as numerous countries and states have legalized its use for either recreational or medicinal purposes in recent years. This creates a myriad of opportunities and challenges for companies considering investment in the sector, particularly in relation to investments across multiple jurisdictions. Find out what’s new in this developing industry sector.
Publication
Cannabis has been considered an illegal substance globally since the creation of the Single Convention on Narcotic Drugs (The Convention) in 1961.
Publication
The maturation of the cannabis sector is presenting an array of opportunities to private producers and retailers.
Publication
In the 12 months leading to legalization in October 2018, Canadian public companies already in the medical cannabis space experienced “jaw-dropping growth” in their market capitalizations, notwithstanding that many reported negative earnings.
Publication
The cannabis sector is a growing and exciting sector.
Publication
Executive Vice President Vestager’s momentous tenure as Commissioner responsible for EU competition policy is nearing its end.
Publication
On November 28, 2023, the European Commission (EC) adopted its first list of Projects of Common Interest (PCIs), i.e., projects within the EU territory, and Projects of Mutual Interest (PMIs), i.e., projects connecting the EU with other countries, including 166 projects implementing the European Green Deal.
Publication
The Securities and Futures Commission (SFC) and the Stock Exchange of Hong Kong Limited (SEHK) issued a Joint Statement on 18 October 2024 in relation to an enhancement in the timeline for the IPO1 application process (Enhanced Application Timeframe) by new listing applicants (the Applicants), taking effect immediately.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023